These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21552020)

  • 1. Outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
    Willegaignon J; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Clin Nucl Med; 2011 Jun; 36(6):440-5. PubMed ID: 21552020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on Willegaignon et al.: outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
    Marcus CS
    Clin Nucl Med; 2011 Jun; 36(6):446. PubMed ID: 21552021
    [No Abstract]   [Full Text] [Related]  

  • 3. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
    de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy.
    Kusakabe K; Yokoyama K; Ito K; Shibuya H; Kinuya S; Ito M; Higashi T; Togawa T; Koizumi K; Yoshimura M; Uchiyama M; Okamoto T; Kanaya S; Kanaya K; Yoneyama T; Ikebuchi H; Yanagida S; Shibata K; Segawa K; Yamamoto A
    Ann Nucl Med; 2012 May; 26(4):370-8. PubMed ID: 22450825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient therapeutic 131I for thyroid cancer.
    Panzegrau B; Gordon L; Goudy GH
    J Nucl Med Technol; 2005 Mar; 33(1):28-30. PubMed ID: 15731017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposure.
    Gabriel S; Farman-Ara B; Bourrelly M; Carpentier O; Sebag F; Palazzo FF; De Micco C; Mancini J; Henry JF; Mundler O; Taïeb D
    Nucl Med Commun; 2011 Sep; 32(9):829-33. PubMed ID: 21633315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
    Al-Shakhrah IA
    Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.
    Parthasarathy KL; Crawford ES
    J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment.
    Al-Haj AN; Lagarde CS; Lobriguito AM
    Health Phys; 2007 Dec; 93(6):656-66. PubMed ID: 17993846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
    Lassmann M; Reiners C; Luster M
    Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
    Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
    Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy.
    Marriott CJ; Webber CE; Gulenchyn KY
    Radiat Prot Dosimetry; 2007; 123(1):62-7. PubMed ID: 16825250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
    Hänscheid H; Lassmann M; Luster M; Kloos RT; Reiners C
    Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the blood picture after radioiodine therapy of thyroid cancer].
    Grünwald F; Schomburg A; Menzel C; Steinecker S; Späth G; Bockisch A; Fimmers R; Hotze AL; Biersack HJ
    Med Klin (Munich); 1994 Oct; 89(10):522-8. PubMed ID: 7808352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
    Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
    Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
    [No Abstract]   [Full Text] [Related]  

  • 16. [Environmental radiation exposure of a thyroid cancer patient resulting from adjuvant iodine radiotherapy].
    Chaś J; Kowalczyk A; Siekierzyński M; Dziuk E; Janiak MK
    Wiad Lek; 2001; 54 Suppl 1():312-20. PubMed ID: 12182042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancer.
    Freudenberg LS; Frömke C; Petrich T; Marlowe RJ; Koska WW; Brandau W; Eising EG; Knust EJ; Bockisch A; Jentzen W
    Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):393-9. PubMed ID: 19856257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
    Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
    Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].
    Schümichen C; Bulczak-Schmidt M; Blattmann H; Pauli-Harnasch C
    Nuklearmedizin; 1984 Oct; 23(5):265-9. PubMed ID: 6522276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dosimetric measurements and early complications in patients with differentiated thyroid carcinomas treated with radioactive iodine].
    Malesević M; Stefanović L; Adzić O; Mihoci Z; Elez D
    Med Pregl; 1992; 45(11-12):427-31. PubMed ID: 1344442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.